Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00721903 · ClinicalTrials.gov registry record · NA
Three Dimensional (3D) Ultrasound in Predicting Response to Breast Cancer Therapies
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT00721903: Completed NA study, sponsored by University of Michigan.
NCT00721903 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 88 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00721903, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how well changes can be determined in malignant masses from ultrasound scans.
Primary Outcome
Self explanatory.
Interventions
- PROCEDURE Ultrasound Scan
- PROCEDURE Mammography and Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2000-03 |
| Est. Completion | 2014-09 |
| Phase | NA |
What the finished NCT00721903 record still lists
NCT00721903 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Ultrasound Scan is the first listed.
NCT00721903 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00721903 about?
NCT00721903 is a clinical study titled "Three Dimensional (3D) Ultrasound in Predicting Response to Breast Cancer Therapies". The purpose of this study is to determine how well changes can be determined in malignant masses from ultrasound scans.
What is the current status of trial NCT00721903?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2000-03. Estimated completion is 2014-09.
What interventions are being tested in trial NCT00721903?
The interventions under investigation include: Ultrasound Scan (PROCEDURE), Mammography and Ultrasound (PROCEDURE).
Who is sponsoring clinical trial NCT00721903?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00721903's enrollment target sits among peer trials
88 972nd of 2000 higher than 1,027 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia